News
Cannabidiol (CBD) and cannabigerol (CBG) are increasingly studied for their therapeutic applications in neurological and vision-related conditions. While lower doses (20–300 mg/day) are effective for mild to moderate symptoms, emerging research suggests high doses (600–1000 mg/day) may provide amplified benefits for certain conditions. Let’s dive into the science supporting these high-dose treatments and their specific applications.
Continue reading
The growing body of research on cannabigerol (CBG) reveals its immense potential as a therapeutic compound. With its anti-inflammatory, neuroprotective, antimicrobial, anticancer, and mood-stabilizing properties, CBG presents a promising avenue for the development of novel treatments for a wide range of health conditions.
At BEYOND CBD our research and products are always on the forefront of the industry, and science just caught up. Our development team is creating an entire line of FULL SPECTRUM CBD ISOLATE PRODUCTS. All the pure CBD, entourage effect you’re going for, terpenes, and all the cannabinoids combined without any of the solvents.
Continue reading
